Prevalence of monoclonal gammopathy of undetermined significance/myeloma in patients with acute osteoporotic vertebral fractures

Acta Haematologica

Volumn 120, Issue 2, 2008, Pages 87-90

  Golombick, Terry ^a   Diamond, Terry ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PLASMA CELL DYSCRASIA; PREVALENCE; PRIORITY JOURNAL; VERTEBRA FRACTURE;

AGED; BONE RESORPTION; CROSS-SECTIONAL STUDIES; FEMALE; FEMORAL NECK FRACTURES; FRACTURES, SPONTANEOUS; GLUCOCORTICOIDS; HUMANS; LUMBAR VERTEBRAE; MALE; MULTIPLE MYELOMA; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARAPROTEINEMIAS; PREVALENCE; RETROSPECTIVE STUDIES; SPINAL INJURIES;

EID: 53549122742     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000162282     Document Type: Article

References (8)

1. Kyle RA, Rajkumar SV: Monoclonal gammopathies of undetermined significance. Best Pract Res Clin Haematol 2005;18:689-707.
2. Melton LJ 3rd, Rajkumar V, Khosla S, Achenbach SJ, Oberg AL, Kyle RA: Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 2004;19:25-30.
3. Bataille R, Chappard D, Basle M-F: Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies. Blood 1996;87:4762-4769.
4. Woitge HW, Horn E, Keck AV, Auler B, Seibel MJ, Pecherstorfer M: Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis. Clin Chem 2001;47:686-693.
5. Diamond T, Levy S, Smith A, Day P, Manoharan A: Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance. Intern Med J 2001;31:272-278.
6. Diamond T, McGuigan L, Barbagallo S, Bryant C: Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. Am J Med 1995;98:459-463.
7. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M: Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002;87:4431-4437.
8. Abrahamsen B, Andersen I, Christensen S, Madsen JS, Brixen K: Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study. BMJ 2005;330:818. DOI: 10.1136/bmj.38376.401701.8F.